A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Of Darolutamide Plus Androgen Deprivation Therapy ADT Compared To Placebo Plus ADT In Patients With High-Risk Biochemical Recurrence BCR Of Prostate Cancer

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05794906

Study #:
STUDY00150110

Start Date:
May 07, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05794906

View Complete Trial Details & Eligibility at ClinicalTrials.gov